Year: All Releases20192018201720162015201420132012 August 28, 2019 Mersana Therapeutics to Present at Upcoming Investor Conferences PDF Version August 20, 2019 Mersana Therapeutics Announces Initiation of Expansion Study of XMT-1536 in Patients with Platinum-Resistant Ovarian Cancer and Non-Small Cell Lung Cancer PDF Version August 8, 2019 Mersana Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Updates PDF Version August 6, 2019 Mersana Therapeutics to Present at the Wedbush PacGrow Healthcare Conference PDF Version August 1, 2019 Mersana Therapeutics to Host Conference Call Announcing Second Quarter 2019 Financial Results and Business Updates PDF Version June 12, 2019 Mersana Therapeutics Announces Appointment of Brian C. DeSchuytner as Senior Vice President of Finance and Product Strategy PDF Version June 1, 2019 Mersana Presents Interim Phase 1 Data for XMT-1536 at the 2019 American Society of Clinical Oncology Annual Meeting PDF Version May 30, 2019 Mersana Therapeutics to Present at the Jefferies 2019 Global Healthcare Conference PDF Version May 20, 2019 Mersana Therapeutics to Present Interim Phase 1 Data on XMT-1536 at the 2019 American Society of Clinical Oncology Annual Meeting PDF Version May 9, 2019 Mersana Therapeutics Announces First Quarter 2019 Financial Results and Provides Business Updates PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
